ARTICLE

Volume 10,Issue 4

Cite this article
6
Citations
18
Views
26 December 2025

Analysis of the Impact of Comprehensive Drug Clinical Evaluation Thinking on Temporary Drug Procurement Management in Hospitals

Nan Jiang*
Show Less
1 Huaixi Community Health Service Center, Qingjiangpu District, Huai'an 223001, Jiangsu, China
JMDS 2025 , 10(4), 108–114; https://doi.org/10.18063/JMDS.v10i4.1194
© 2025 by the Author. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Objective: To study and analyze the impact of comprehensive drug clinical evaluation thinking on temporary drug procurement management in hospitals. Methods: 394 temporary drug purchase applications in our hospital from January 2022 to December 2023 were selected as the research objects and divided into two groups according to time. January 2022 to December 2022 was the conventional management group (n=197), which adopted the temporary procurement management model of conventional drugs; January 2023 to December 2023 was the comprehensive thinking group (n=197), which adopted the comprehensive clinical evaluation thinking management model of drugs. Compare the purchasing decisions and categories of purchased drugs between the two groups. Results: The temporary drug purchase application rate and pre-audit failure rate of the comprehensive thinking group were lower than those of the control group, and the temporary purchase execution rate was higher than that of the control group. The difference was statistically significant (P<0.05). The hospitals' temporary drug purchases mostly included immunomodulatory drugs and anti-infective drugs. Among the drug categories purchased by the two groups, the purchase of anti-infective drugs, nervous system drugs, respiratory system drugs and special/other therapeutic drugs was statistically significant. The conventional management group was significantly higher than the comprehensive thinking group (P<0.05). Conclusion: The application of drug clinical comprehensive evaluation thinking in hospital drug temporary procurement management can effectively improve the scientificity, rationality and execution efficiency of procurement decisions, optimize the drug catalog structure, and improve the overall level of hospital drug management.

Keywords
hospital drugs
temporary procurement
thinking on comprehensive clinical evaluation of drugs
References

[1] Dong HM, Zhong X, 2024, Application Effect of Comprehensive Clinical Drug Evaluation Thinking in Temporary Drug Procurement Management in Hospitals. Smart Health, 10(26):  138-140.

[2] Yang X, Li C, Cai YQ, et al., 2023, Application Practice of Comprehensive Clinical Drug Evaluation Thinking in Temporary Drug Procurement Management in Hospitals. Chinese Pharmacy, 34(10): 1172-1176.

[3] Qiao Y, Ma FY, Han YB, et al., 2025, Analysis on the Evaluation Mechanism and Methodology of Cases Related to Comprehensive Clinical Evaluation of Drugs in China. Chinese Pharmacy, 36(2): 146-153.

[4] Yan XJ, 2024, Application of Failure Mode and Impact Analysis Model in the Management of Selected Drugs in National Centralized Procurement of Hospitals. Chinese Science and Technology Journal Database (Abstract Edition) Social Sciences, (4): 0021-0024.

[5] Bian XJ, 2020, Analysis of Accounting Procurement and Inventory Management of Pharmaceutical Materials in Hospital Drug Management. Economic Research Guide, (15):  73-74.

[6] Weng SL, Mo GD, Huang CY, et al., 2021, The Impact of Pharmaceutical Zero Inventory Management Based on the Pharmaceutical Group Procurement Model on Hospital Drug Supply and Pharmacy Management. Anti-infectious Pharmacy, 18(3): 428-433.

[7] Qu WJ, Bai RN, Cui L, et al., 2024, Analysis of Drug Procurement Model in Multiple Districts of Public Hospitals Based on Joint Inventory. Pharmacy Practice and Service, 42(7): 315-318.

[8] Lan T, Guan L, Pang X, et al., 2022, Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the Drug Expenditures of Patients Treated in Outpatient and Emergency Departments in a Large Tertiary Level-A Hospital in China: A Single Centre, Interrupted Time Series. Journal of Clinical Pharmacy and Therapeutics, 47(1): 104-111.

[9] Zhou AJ, 2019, Research on Accounting Procurement and Inventory Management of Pharmaceutical Materials in Hospital Drug Management. Modern Economic Information, (18):177-178.

[10] Du ZX, Lan HD, Liu SD, et al., 2023, Analysis of the Current Situation of Temporary Drug Procurement Management in Medical Institutions. Chinese Science and Technology Journal Database (Full-text version) Medicine and Health, (11): 1-4.

[11] Chen LN, Liu YJ, Su J, et al., 2023, Research on Procurement and Inventory Management of Western Medicines in Medical Institutions. Chinese Science and Technology Journal Database (Full-text version) Medicine and Health, (7): 0026-0029.

[12] Zhang Y, Zhang Y, 2023, Application of PDCA Management in Improving the Completion Rate of Centralized Drug Procurement. Journal of Traditional Chinese Medicine Management, 31(14): 170-172.

Share
Back to top